tag non-optimised-medication-therapy 
Drug Discovery World
NOVEMBER 9, 2023
Following this, Rebecca Croasdale-Wood, PhD, Director, Augmented Biologics Discovery & Design, Biologics Engineering, Oncology, AstraZeneca, will present: ‘Benchmarking the impact of AI biologics discovery and optimisation for pharma’. Croasdale-Wood will then participate in a keynote chat, interviewed by Miho.
Drug Discovery World
NOVEMBER 13, 2023
Pietro Sormanni, PhD, Group Leader, Royal Society University Research Fellow, Chemistry of Health, Yusuf Hamied Department of Chemistry, University of Cambridge, on: ‘Third-generation approaches of antibody discovery and optimisation’. Jürgen Kuball, PhD, Head, Hematology, University Medical Center Utrecht, on: ‘gdT cell inspired therapies’.
Expert insights. Personalized for you.
52 
Let's personalize your content